Netarsudil Drops After Retinal Detachment Surgery
Part of Eyes & vision clinical trials.
This study tests whether netarsudil eye drops can prevent vision-threatening scar tissue (proliferative vitreoretinopathy) after retinal detachment repair. If you are having surgery for a retinal detachment, these drops may reduce the risk of complications.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have a retinal detachment that needs surgery within 28 days of symptoms starting
- You are having vitrectomy (removal of gel inside eye) with or without a scleral buckle
- You have not had prior glaucoma surgery or used netarsudil drops in the affected eye
- You do not have active eye infections, severe inflammatory eye disease, or diabetic eye disease
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies a “dropless” method (fewer post-surgery eye drops) after pars plana vitrectomy, a surgery used to repair a retinal detachment. It may help by improving comfort and simplifying recovery for people having this specific type of retinal detachment repair.
This study looks at why some patients develop high eye pressure or retinal detachment again after surgery to repair retinal detachment with silicone oil. It aims to find risk factors so doctors can better prevent these complications.
This trial tests if injecting a medication called methotrexate into the eye during retinal detachment surgery can prevent scar tissue from forming. Scar tissue can sometimes cause the retina to detach again, so this treatment might lower that risk.
This trial compares two types of surgery for people with a retinal detachment who still have their natural lens (no prior cataract surgery). One group gets vitrectomy alone; the other gets vitrectomy plus the lens removed at the same time. The goal is to see which approach leads to better outcomes.
This trial tests a shot of topotecan into the eye during retinal detachment surgery to try to prevent or treat a scar-like condition called proliferative vitreoretinopathy that can cause vision loss. It is for adults who are already having surgery for a retinal tear.
This study uses special imaging to see how the eye-pressure-lowering medication netarsudil (Rhopressa) works on the part of your eye that drains fluid. Researchers want to understand whether it helps restore normal drainage in people with high eye pressure or glaucoma.
Hear when a new Rhegmatogenous Retinal Detachment trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.